首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   350篇
  免费   13篇
  国内免费   1篇
林业   22篇
农学   9篇
基础科学   1篇
  55篇
综合类   54篇
农作物   22篇
水产渔业   9篇
畜牧兽医   165篇
园艺   9篇
植物保护   18篇
  2024年   1篇
  2023年   3篇
  2022年   10篇
  2021年   10篇
  2020年   10篇
  2019年   10篇
  2018年   9篇
  2017年   11篇
  2016年   6篇
  2015年   8篇
  2014年   12篇
  2013年   17篇
  2012年   30篇
  2011年   21篇
  2010年   11篇
  2009年   16篇
  2008年   21篇
  2007年   22篇
  2006年   12篇
  2005年   18篇
  2004年   16篇
  2003年   15篇
  2002年   22篇
  2001年   2篇
  2000年   3篇
  1999年   3篇
  1998年   4篇
  1997年   2篇
  1996年   2篇
  1995年   4篇
  1994年   1篇
  1993年   2篇
  1992年   2篇
  1991年   2篇
  1990年   3篇
  1989年   5篇
  1988年   6篇
  1986年   1篇
  1984年   1篇
  1982年   3篇
  1980年   1篇
  1975年   1篇
  1967年   1篇
  1966年   2篇
  1963年   1篇
  1961年   1篇
排序方式: 共有364条查询结果,搜索用时 15 毫秒
1.
2.
An 8-day-old Arabian-Morgan cross colt underwent cardiac evaluation. The foal was tachycardic, tachypneic, exercise intolerant and had a loud right-sided heart murmur and cyanotic mucous membranes. Total anomalous pulmonary venous connection was diagnosed with echocardiography and confirmed at postmortem examination. Total anomalous pulmonary venous connection is a very rare congenital cardiac abnormality that has not been reported before in the horse.  相似文献   
3.
BACKGROUND: Dilated cardiomyopathy (DCM) is characterized by reduced systolic function, heightened sympathetic tone, and high morbidity and mortality. Little is known regarding the safety and efficacy of beta-blocker treatment in dogs with DCM. HYPOTHESIS: Carvedilol improves echocardiographic and neurohormonal variables in dogs with DCM over a 4-month treatment period. METHODS: Prospective, placebo-controlled, double-blinded randomized study. Dogs with DCM underwent echocardiography, ECG, thoracic radiographs, and neurohormonal profiling, followed by titration onto carvedilol (0.3 mg/kg q12h) or placebo over a 4-week period and subsequently received 3 months of therapy. Primary study endpoints included left ventricular volume and function. RESULTS: Sixteen dogs received carvedilol and 7 received placebo. At study end, 13 carvedilol dogs and 5 placebo dogs were alive. There was no difference in the mean percentage change in left ventricular volume at end-diastole (LVVd), left ventricular end-systolic volume (LVVs), and ejection fraction (EF) between treatment groups, suggesting that both groups experienced similar amounts of disease progression. Carvedilol treatment did not result in significant changes in neurohormonal activation, radiographic heart size, heart rate, or owner perceived quality-of-life. Baseline B-type natriuretic peptide (BNP) predicted dogs in the carvedilol-treated group that maintained or improved their EF over the study duration. CONCLUSIONS AND CLINICAL IMPORTANCE: Carvedilol administration did not improve echocardiographic or neurohormonal indicators of heart function. The lack of effect may be related to severity of disease, carvedilol dose, or brevity of follow-up time. Statistical power of the present study was adversely affected by a high fatality rate in study dogs and small sample size.  相似文献   
4.
In this paper, a new microcomputer distance protection scheme with high property-cost ratio has been approached. The paper presents the performance equations based on the symmetrical components of current and voltage, proposes a new (1,a) coordinate plane and derives a Fourier symmetrical component algorithem with high accuracy and less calculation amount on the (1,a) plane. The protection program is debugged on the developing system of single chip computer. The digital imitation tests indicate that the proposed relaying system is satisfactory.  相似文献   
5.
The marine environment is a rich source of biologically active molecules for the treatment of human diseases, especially cancer. The adaptation to unique environmental conditions led marine organisms to evolve different pathways than their terrestrial counterparts, thus producing unique chemicals with a broad diversity and complexity. So far, more than 36,000 compounds have been isolated from marine micro- and macro-organisms including but not limited to fungi, bacteria, microalgae, macroalgae, sponges, corals, mollusks and tunicates, with hundreds of new marine natural products (MNPs) being discovered every year. Marine-based pharmaceuticals have started to impact modern pharmacology and different anti-cancer drugs derived from marine compounds have been approved for clinical use, such as: cytarabine, vidarabine, nelarabine (prodrug of ara-G), fludarabine phosphate (pro-drug of ara-A), trabectedin, eribulin mesylate, brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, belantamab mafodotin, plitidepsin, and lurbinectedin. This review focuses on the bioactive molecules derived from the marine environment with anticancer activity, discussing their families, origin, structural features and therapeutic use.  相似文献   
6.
Rapid wastage of Alaska glaciers and their contribution to rising sea level   总被引:1,自引:0,他引:1  
We have used airborne laser altimetry to estimate volume changes of 67 glaciers in Alaska from the mid-1950s to the mid-1990s. The average rate of thickness change of these glaciers was -0.52 m/year. Extrapolation to all glaciers in Alaska yields an estimated total annual volume change of -52 +/- 15 km3/year (water equivalent), equivalent to a rise in sea level (SLE) of 0.14 +/- 0.04 mm/year. Repeat measurements of 28 glaciers from the mid-1990s to 2000-2001 suggest an increased average rate of thinning, -1.8 m/year. This leads to an extrapolated annual volume loss from Alaska glaciers equal to -96 +/- 35 km3/year, or 0.27 +/- 0.10 mm/year SLE, during the past decade. These recent losses are nearly double the estimated annual loss from the entire Greenland Ice Sheet during the same time period and are much higher than previously published loss estimates for Alaska glaciers. They form the largest glaciological contribution to rising sea level yet measured.  相似文献   
7.
Transtracheal wash and bronchoalveolar lavage are diagnostic techniques that have been adopted from human medicine for monitoring inflammatory changes in the airway of the horse. Transendoscopic biopsy has also proven to be a valuable tool for obtaining samples of the airway mucosa in human patients. A transendoscopic technique was developed in this study for obtaining a respiratory mucosal biopsy from standing, sedated horses. Six normal adult horses were sampled at eight-week intervals for a total of three sample periods. Horses were monitored for adverse effects of the technique and none were noted. Sample sites were completely healed after eight weeks with no gross or histologic abnormalities. Biopsy samples were 3 to 4 millimeters in diameter, and 17 of 18 samples provided interpretable histological sections. Methods for handling, staining and evaluating tissue were also developed. The results of this study demonstrated that airway mucosal biopsy is a safe, repeatable technique that can be performed in the sedated, standing horse.  相似文献   
8.
The confirmatory diagnosis of Mycobacterium bovis (M. bovis) in animal samples is carried out by culture in Stonebrink media. However, culture is very slow because of the extremely long duplication time of the bacillus and difficult because of the scarcity of bacilli in diagnostic samples. This study describes the development of a single-tube touch-down polymerase chain reaction (PCR) protocol for the detection of M. bovis using primers that target the IS6110 element. Spiked water and milk as well as routine diagnostic samples (milk and nasal swabs) from M. bovis-positive cattle were tested. This protocol allows the rapid and sensitive detection of M. bovis in bovine samples by enhancing the sensitivity of standard PCR amplification.  相似文献   
9.
10.
通过15种植物病原真菌的培养滤液对草坪杂草稗草、反枝苋、蒲公英、车前、苘麻进行种子萌发抑制试验,对其除草活性进行了初步研究。结果表明:玉米小斑病菌、黄瓜黑星病菌的培养滤液对稗草、蒲公英、车前都表现出显著的除草活性;玉米大斑病菌的培养滤液仅对稗草和蒲公英表现显著的除草活性;烟草赤星病菌的培养滤液仅对车前和苘麻表现了显著的除草活性。安全试验表明:烟草赤星病菌的培养滤液对黑麦草和早熟禾种子的萌发、芽和根的生长表现安全;黄瓜黑星病菌的培养滤液仅对黑麦草种子的萌发、芽和根的生长表现安全。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号